Search Results - samaya+krishnan

1 Results Sort By:
Novel Inhibitors of Proto-Oncogene PELP1
Novel peptide inhibitors that disrupts the functional interactions of oncogenic protein PELP1 have been discovered by researchers at UT Health San Antonio. These inhibitors can be used for treatment of cancers that are characterized as over-expressing PELP1.Background:PELP1 overexpression, noted in many hormone-related cancers such as breast, prostate,...
Published: 11/8/2023   |   Inventor(s): Ratna Vadlamudi, Monica Mann, Samaya Krishnan, Gangadhara Sareddy
Keywords(s):  
Category(s): Therapeutics > Small Molecule, Clinical Specialty > Oncology